US gives go ahead to Dr Reddy's for osteoporosis drug
Dr Reddy's Laboratories has received US Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.

Dr Reddy's Laboratories has received US Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.
[caption id="attachment_297303" align="alignleft" width="380" caption="The tablets are the generic version of Boniva, a brand sold by a unit of Swiss drugmaker Roche. This is a representational picture."]
[/caption]
The tablets are the generic version of Boniva, a brand sold by a unit of Swiss drugmaker Roche.
Cipla , another Indian drugmaker, received US regulatory approval for AIDS treatment drug nevirapine, the website showed.
The drug is a generic version of German drugmaker Boehringer Ingelheim's Viramune tablets.
Reuters

BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents
Eight Russian judokas barred from world championships after Ukraine boycott
Old video of Donald Trump listening to Taylor Swift’s ‘Blank Space’ takes over internet; watch
SA20: Ex-New Zealand all-rounder Jacob Oram appointed MI Cape Town bowling coach
FIFA World Cup: Morgan Freeman, Jung Kook headline day one before Ecuador defeats hosts Qatar
